OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer

Cheng Yan1, Huijie Yang2, Peng Su3

  • 1School of Medicine, Key Laboratory of Nano-carbon Modified Film Technology of Henan Province, Diagnostic Laboratory of Animal Diseases, Xinxiang University, Xinxiang, 453003, Henan, China.

Oncogene
|October 21, 2022
PubMed

Insights

Researchers identified OTUB1 as a key factor in gastric cancer progression. This deubiquitinase stabilizes YAP protein, promoting cancer cell stemness and correlating with poor patient survival, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gastric cancer is a leading cause of cancer mortality worldwide, with limited effective targeted therapies.
  • The Hippo-signaling pathway, particularly the YAP protein, is increasingly recognized for its critical role in gastric cancer development and progression.
  • While YAP phosphorylation is well-studied, its regulation via ubiquitination and deubiquitination is crucial for understanding Hippo signaling in cancer.

Purpose of the Study:

  • To identify critical deubiquitinases (DUBs) regulating the Hippo-signaling pathway in gastric cancer.
  • To elucidate the role of OTUB1 in gastric cancer cell stemness, progression, and YAP protein stability.
  • To investigate the clinical relevance of OTUB1 expression in gastric cancer patients.

Main Methods:

  • Utilized a Deubiquitinase (DUB) siRNA library to screen for key regulators of Hippo signaling.
  • Investigated the interaction between OTUB1 and YAP protein, including specific deubiquitination sites.
  • Analyzed clinical data to correlate OTUB1 expression levels with YAP activity and patient survival outcomes.

Main Results:

  • Discovered OTUB1 as a critical deubiquitinase that stabilizes YAP protein by deubiquitinating it at multiple lysine residues (K90, K280, K343, K494, K497).
  • Demonstrated that OTUB1 facilitates gastric cancer cell stemness and progression.
  • Found elevated OTUB1 expression in gastric cancer tissues, which positively correlated with YAP activity and predicted poor patient survival.

Conclusions:

  • OTUB1 functions as a novel deubiquitinase for the Hippo/YAP axis in gastric cancer.
  • OTUB1-mediated YAP stabilization promotes gastric cancer progression and is associated with adverse clinical outcomes.
  • OTUB1 represents a potential therapeutic target for YAP-driven gastric cancers.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K